From the American Academy of Ophthalmology

This pilot study evaluated the safety and efficacy of a new in-the-bag Fresnel prism IOL designed to deviate the image from diseased to healthy retina in eyes with advanced AMD. Subjects included three patients with bilateral AMD and cataract who underwent unilateral implantation of the prismatic IOL. All patients reported displacement of the scotoma and no diplopia. The authors conclude that this new technology merits further research because it may benefit many patients with stable end-stage AMD. Journal of Cataract & Refractive Surgery, July 2014